4//SEC Filing
Mazzo David J 4
Accession 0001334549-26-000003
CIK 0000320017other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:09 PM ET
Size
13.6 KB
Accession
0001334549-26-000003
Insider Transaction Report
Form 4
Mazzo David J
DirectorPresident & CEO
Transactions
- Award
Common Stock
[F1][F2]2026-01-09+81,000→ 352,986 total - Tax Payment
Common Stock
[F3][F2]2026-01-09$1.97/sh−10,503$20,691→ 342,483 total - Tax Payment
Common Stock
[F3][F2]2026-01-09$1.97/sh−10,515$20,715→ 331,968 total - Tax Payment
Common Stock
[F3][F2]2026-01-09$1.97/sh−12,224$24,081→ 319,744 total - Tax Payment
Common Stock
[F3][F2]2026-01-09$1.97/sh−7,854$15,472→ 311,890 total - Award
Stock Option (Right to Buy)
[F4]2026-01-09+40,000→ 40,000 totalExercise: $1.97From: 2026-01-09Exp: 2036-01-09→ Common Stock (40,000 underlying)
Footnotes (4)
- [F1]Represents 81,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
- [F2]Includes 124,750 unvested restricted stock.
- [F3]Shares withheld as payment of a tax liability on vesting of restricted stock.
- [F4]One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third anniversaries of the grant date.
Signature
James Nisco, Attorney-in-Fact for David J. Mazzo|2026-01-13
Documents
Issuer
LISATA THERAPEUTICS, INC.
CIK 0000320017
Entity typeother
Related Parties
1- filerCIK 0001334549
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 4:09 PM ET
- Size
- 13.6 KB